Tonix Pharmaceuticals Holding Corp.
TNXP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$32,010 | -$28,272 | -$16,829 | -$22,108 |
| Dep. & Amort. | $461 | $483 | $493 | $496 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,800 | $1,423 | $882 | $894 |
| Change in WC | -$405 | $7,416 | -$3,282 | $6,416 |
| Other Non-Cash | $1,372 | $4,117 | $2,157 | -$328 |
| Operating Cash Flow | -$28,782 | -$14,833 | -$16,579 | -$14,630 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$962 | -$527 | -$6 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$2,012 | $0 | $0 |
| Investing Cash Flow | -$962 | -$2,539 | -$6 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$9,650 | -$705 |
| Stock Issued | $0 | $13,895 | $62,230 | $85,859 |
| Stock Repurch. | $0 | -$2,902 | -$3,047 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $94,861 | $0 | $0 | $339 |
| Financing Cash Flow | $94,861 | $10,993 | $49,533 | $85,154 |
| Forex Effect | -$4 | -$4 | -$9 | $24 |
| Net Chg. in Cash | $65,113 | -$6,383 | $32,939 | $70,544 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $126,236 | $132,619 | $99,680 | $29,136 |
| End Cash | $191,349 | $126,236 | $132,619 | $99,680 |
| Free Cash Flow | -$29,744 | -$17,372 | -$16,585 | -$14,633 |